General MedicationsTOPICALGeneric
DESOXIMETASONE
DESOXIMETASONE
Standard Dose
0.25%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DESOXIMETASONE is listed in Drugs@FDA under application 209595 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DESOXIMETASONE Form and strength CREAM;TOPICAL - 0.25% Sponsor COSETTE Submission history Latest submission status date: 2020-03-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview DESOXIMETASONE is listed in Drugs@FDA under application 209595 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DESOXIMETASONE Form and strength CREAM;TOPICAL - 0.25% Sponsor COSETTE Submission history Latest submission status date: 2020-03-04 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.